• Pediatric sleep disorders are very common, affecting up to one third of all children.
  • Most children with sleep disorders (e.g., with behavioral insomnia of childhood) do not require pharmacologic treatment, and can be managed with behavioral and environmental interventions.
  • Obstructive sleep apnea affects up to 4% of children. It is specifically associated with deleterious neurocognitive, developmental, and behavioral outcomes in children. Adenotonsillectomy is generally the first line of therapy and can be associated with reversal of some of these adverse sequelae.
  • Relevant disorders to this monograph include behavioral insomnia of childhood, obstructive sleep apnea (OSA), narcolepsy, delayed sleep phase disorder/syndrome (DSPD/DSPS), and inadequate sleep hygiene.

Share this page

Use of this content is subject to our disclaimer